A detailed history of Met Life Investment Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 5,681 shares of RARE stock, worth $248,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,681
Previous 5,608 1.3%
Holding current value
$248,543
Previous $230,000 36.96%
% of portfolio
0.0%
Previous 0.0%

Shares

67 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.21 - $59.36 $2,935 - $4,333
73 Added 1.3%
5,681 $315,000
Q2 2024

Aug 13, 2024

BUY
$37.42 - $51.61 $31,021 - $42,784
829 Added 17.35%
5,608 $230,000
Q1 2024

May 14, 2024

BUY
$43.02 - $53.69 $205,592 - $256,584
4,779 New
4,779 $223,000
Q4 2023

Feb 14, 2024

BUY
$31.73 - $49.19 $19,291 - $29,907
608 Added 14.63%
4,764 $227,000
Q3 2023

May 09, 2024

BUY
$34.92 - $46.66 $24,444 - $32,661
700 Added 20.25%
4,156 $148,000
Q3 2023

Apr 29, 2024

BUY
$34.92 - $46.66 $69 - $93
2 Added 0.05%
4,156 $148,000
Q3 2023

Nov 14, 2023

BUY
$34.92 - $46.66 $69 - $93
2 Added 0.05%
4,156 $148,000
Q2 2023

Apr 29, 2024

BUY
$37.35 - $52.15 $155,151 - $216,631
4,154 New
4,154 $191,000
Q2 2023

Aug 10, 2023

BUY
$37.35 - $52.15 $26,070 - $36,400
698 Added 20.2%
4,154 $191,000
Q1 2023

May 09, 2024

BUY
$36.99 - $48.71 $127,837 - $168,341
3,456 New
3,456 $139 Million
Q1 2023

May 15, 2023

BUY
$36.99 - $48.71 $295 - $389
8 Added 0.23%
3,456 $138,000
Q4 2022

May 10, 2024

SELL
$33.72 - $46.33 $2,765 - $3,799
-82 Reduced 2.32%
3,448 $159,000
Q4 2022

Jun 14, 2023

SELL
$33.72 - $46.33 $269 - $370
-8 Reduced 0.23%
3,448 $159,000
Q4 2022

Mar 22, 2023

SELL
$33.72 - $46.33 $2,765 - $3,799
-82 Reduced 2.32%
3,448 $159,000
Q4 2022

Feb 15, 2023

SELL
$33.72 - $46.33 $2,765 - $3,799
-82 Reduced 2.32%
3,448 $159,000
Q3 2022

May 10, 2024

SELL
$39.96 - $66.14 $159 - $264
-4 Reduced 0.11%
3,530 $146,000
Q3 2022

Jun 14, 2023

BUY
$39.96 - $66.14 $2,957 - $4,894
74 Added 2.14%
3,530 $146,000
Q3 2022

Mar 22, 2023

SELL
$39.96 - $66.14 $159 - $264
-4 Reduced 0.11%
3,530 $146,000
Q3 2022

Nov 14, 2022

SELL
$39.96 - $66.14 $159 - $264
-4 Reduced 0.11%
3,530 $146,000
Q2 2022

May 10, 2024

BUY
$45.8 - $85.4 $3,068 - $5,721
67 Added 1.93%
3,534 $210,000
Q2 2022

Jun 20, 2023

BUY
$45.8 - $85.4 $3,572 - $6,661
78 Added 2.26%
3,534 $210,000
Q2 2022

Mar 22, 2023

BUY
$45.8 - $85.4 $3,068 - $5,721
67 Added 1.93%
3,534 $210,000
Q2 2022

Aug 11, 2022

BUY
$45.8 - $85.4 $3,068 - $5,721
67 Added 1.93%
3,534 $211,000
Q1 2022

May 10, 2024

BUY
$62.2 - $84.4 $215,647 - $292,614
3,467 New
3,467 $251,000
Q1 2022

Jun 20, 2023

BUY
$62.2 - $84.4 $684 - $928
11 Added 0.32%
3,467 $251,000
Q1 2022

Mar 22, 2023

BUY
$62.2 - $84.4 $195,245 - $264,931
3,139 Added 957.01%
3,467 $251,000
Q1 2022

May 12, 2022

BUY
$62.2 - $84.4 $215,647 - $292,614
3,467 New
3,467 $252,000
Q4 2021

Feb 15, 2022

SELL
$73.71 - $87.86 $24,176 - $28,818
-328 Closed
0 $0
Q3 2021

Mar 22, 2023

SELL
$77.92 - $102.4 $1.81 Million - $2.38 Million
-23,222 Reduced 98.61%
328 $29,000
Q3 2021

Nov 15, 2021

BUY
$77.92 - $102.4 $25,557 - $33,587
328 New
328 $30,000
Q2 2021

Aug 16, 2021

SELL
$92.19 - $115.71 $2.17 Million - $2.72 Million
-23,550 Closed
0 $0
Q1 2021

May 17, 2024

BUY
$106.9 - $167.73 $2.01 Million - $3.15 Million
18,771 Added 392.78%
23,550 $2.68 Million
Q1 2021

Jun 26, 2023

BUY
$106.9 - $167.73 $2.15 Million - $3.37 Million
20,094 Added 581.42%
23,550 $2.68 Billion
Q1 2021

Mar 22, 2023

SELL
$106.9 - $167.73 $142,390 - $223,416
-1,332 Reduced 5.35%
23,550 $2.68 Million
Q1 2021

May 14, 2021

SELL
$106.9 - $167.73 $142,390 - $223,416
-1,332 Reduced 5.35%
23,550 $2.68 Million
Q4 2020

May 24, 2024

BUY
$84.4 - $177.39 $83,893 - $176,325
994 Added 4.16%
24,882 $3.44 Million
Q4 2020

Jun 22, 2023

BUY
$84.4 - $177.39 $1.81 Million - $3.8 Million
21,426 Added 619.97%
24,882 $3.44 Million
Q4 2020

Mar 22, 2023

BUY
$84.4 - $177.39 $83,893 - $176,325
994 Added 4.16%
24,882 $3.44 Million
Q4 2020

Feb 16, 2021

BUY
$84.4 - $177.39 $83,893 - $176,325
994 Added 4.16%
24,882 $3.44 Million
Q3 2020

May 24, 2024

SELL
$72.98 - $90.0 $78,015 - $96,210
-1,069 Reduced 4.28%
23,888 $1.96 Billion
Q3 2020

Jun 26, 2023

BUY
$72.98 - $90.0 $1.49 Million - $1.84 Million
20,432 Added 591.2%
23,888 $1.96 Million
Q3 2020

Mar 22, 2023

SELL
$72.98 - $90.0 $78,015 - $96,210
-1,069 Reduced 4.28%
23,888 $1.96 Million
Q3 2020

Nov 13, 2020

SELL
$72.98 - $90.0 $78,015 - $96,210
-1,069 Reduced 4.28%
23,888 $1.96 Million
Q2 2020

May 24, 2024

BUY
$46.91 - $78.22 $946,549 - $1.58 Million
20,178 Added 422.22%
24,957 $1.95 Billion
Q2 2020

Jun 26, 2023

BUY
$46.91 - $78.22 $1.01 Million - $1.68 Million
21,501 Added 622.14%
24,957 $1.95 Million
Q2 2020

Mar 22, 2023

BUY
$46.91 - $78.22 $98,604 - $164,418
2,102 Added 9.2%
24,957 $1.95 Million
Q2 2020

Aug 14, 2020

BUY
$46.91 - $78.22 $98,604 - $164,418
2,102 Added 9.2%
24,957 $1.95 Million
Q1 2020

Jul 12, 2023

BUY
$33.8 - $62.9 $655,686 - $1.22 Million
19,399 Added 561.31%
22,855 $1.02 Million
Q1 2020

Mar 22, 2023

SELL
$33.8 - $62.9 $54,316 - $101,080
-1,607 Reduced 6.57%
22,855 $1.02 Million
Q1 2020

May 15, 2020

SELL
$33.8 - $62.9 $54,316 - $101,080
-1,607 Reduced 6.57%
22,855 $1.02 Million
Q4 2019

Jul 12, 2023

BUY
$36.08 - $45.83 $757,896 - $962,704
21,006 Added 607.81%
24,462 $1.04 Million
Q3 2019

Jul 12, 2023

BUY
$42.5 - $63.11 $892,755 - $1.33 Million
21,006 Added 607.81%
24,462 $1.05 Million
Q3 2019

Mar 22, 2023

BUY
$42.5 - $63.11 $92,055 - $136,696
2,166 Added 9.71%
24,462 $1.05 Million
Q3 2019

Nov 14, 2019

BUY
$42.5 - $63.11 $92,055 - $136,696
2,166 Added 9.71%
24,462 $1.05 Million
Q2 2019

Jul 12, 2023

BUY
$54.93 - $74.36 $1.15 Million - $1.56 Million
21,006 Added 607.81%
24,462 $1.55 Million
Q1 2019

Jul 13, 2023

BUY
$39.87 - $69.36 $751,150 - $1.31 Million
18,840 Added 545.14%
22,296 $1.55 Million
Q1 2019

Mar 22, 2023

BUY
$39.87 - $69.36 $82,491 - $143,505
2,069 Added 10.23%
22,296 $1.55 Million
Q1 2019

May 15, 2019

BUY
$39.87 - $69.36 $82,491 - $143,505
2,069 Added 10.23%
22,296 $1.55 Million
Q4 2018

Jul 13, 2023

BUY
$38.89 - $77.3 $652,224 - $1.3 Million
16,771 Added 485.27%
20,227 $879,000
Q4 2018

Mar 22, 2023

SELL
$38.89 - $77.3 $461,274 - $916,855
-11,861 Reduced 36.96%
20,227 $879,000
Q4 2018

Feb 14, 2019

SELL
$38.89 - $77.3 $461,274 - $916,855
-11,861 Reduced 36.96%
20,227 $879,000
Q3 2018

Jul 13, 2023

BUY
$71.81 - $90.15 $1.2 Million - $1.51 Million
16,771 Added 485.27%
20,227 $1.54 Million
Q3 2018

Mar 22, 2023

BUY
$71.81 - $90.15 $2.06 Million - $2.58 Million
28,640 Added 830.63%
32,088 $2.45 Million
Q3 2018

Nov 14, 2018

BUY
$71.81 - $90.15 $759,965 - $954,057
10,583 Added 49.21%
32,088 $2.45 Million
Q2 2018

Aug 15, 2018

BUY
$48.54 - $85.31 $67,130 - $117,983
1,383 Added 6.87%
21,505 $1.65 Million
Q1 2018

May 15, 2018

BUY
$44.33 - $58.52 $80,104 - $105,745
1,807 Added 9.87%
20,122 $1.03 Million
Q4 2017

Feb 15, 2018

BUY
$43.54 - $57.32 $797,435 - $1.05 Million
18,315
18,315 $849,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.